Anti-N-methyl-D-aspartate receptor encephalitis in adult patients requiring intensive care

American Journal of Respiratory and Critical Care Medicine

Volumn 195, Issue 4, 2017, Pages 491-499

  De Montmollin, Etienne ^a   Demeret, Sophie ^b   Brulé, Noëlle ^c   Conrad, Marie ^d   Dailler, Frédéric ^e   Lerolle, Nicolas ^f   Navellou, Jean Christophe ^g   Schwebel, Carole ^h   Alves, Mikaël ⁱ   Cour, Martin ^j   Engrand, Nicolas ^k   Tonnelier, Jean Marie ^l   Maury, Eric ^m   Ruckly, Stéphane ⁿ   Picard, Géraldine ^e   Rogemond, Véronique ^e   Magalhaes, Éric ^o   Sharshar, Tarek ^p   Timsit, Jean François ^n,o   Honnorat, Jérome ^e,q   Sonneville, Romain ^o,r   more..

^a Centre Hospitalier de Saint Denis   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e HÔPITAL NEUROLOGIQUE   (France)

^f ANGERS UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^h GRENOBLE UNIVERSITY HOSPITAL   (France)

ⁱ CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^j EDOUARD HERRIOT HOSPITAL   (France)

^k FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^l SERVICE DE RHUMATOLOGIE   (France)

^m HÔPITAL SAINT ANTOINE   (France)

ⁿ INSERM   (France)

^o BICHAT HOSPITAL   (France)

^p RAYMOND POINCARÉ HOSPITAL   (France)

^q CNRS   (France)

^r Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

more..

Author keywords

Anti N methyl D aspartate receptor; Critical care; Encephalitis; Immunotherapy; Incidence

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; RITUXIMAB; STEROID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; AGED; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMUNOTHERAPY; INTENSIVE CARE; INTENSIVE CARE UNIT; LEUKOCYTE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVARY TERATOMA; PLASMA EXCHANGE; PRIORITY JOURNAL; RANKIN SCALE; RETROSPECTIVE STUDY; SEIZURE; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SMALL CELL LUNG CANCER; STEROID THERAPY; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; BRAIN; CEREBROSPINAL FLUID; CLINICAL TRIAL; FRANCE; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; NEUROIMAGING; PATHOPHYSIOLOGY; PLASMAPHERESIS; PROCEDURES; PROGNOSIS; SECONDARY PREVENTION; SEX RATIO; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; BRAIN; FEMALE; FRANCE; HUMANS; IMMUNOGLOBULINS; IMMUNOTHERAPY; INTENSIVE CARE UNITS; MALE; NEUROIMAGING; PLASMAPHERESIS; PROGNOSIS; RECEPTORS, N-METHYL-D-ASPARTATE; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; SEX DISTRIBUTION; STEROIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85014897107     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201603-0507OC     Document Type: Article

References (26)

1. Singh TD, Fugate JE, Rabinstein AA. The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology 2015; 84: 359-366.
2. Thakur KT, Motta M, Asemota AO, Kirsch HL, Benavides DR, Schneider EB, McArthur JC, Geocadin RG, Venkatesan A. Predictors of outcome in acute encephalitis. Neurology 2013; 81:793-800.
3. Sonneville R, Gault N, de Montmollin E, Klein IF, Mariotte E, Chemam S, Tubach F, Mourvillier B, Timsit JF, Wolff M, et al. Clinical spectrum and outcomes of patients with encephalitis requiring intensive care. Eur J Neurol 2015; 22:6-16, e1.
4. Dalmau J, Rosenfeld MR. Autoimmune encephalitis update. Neuro-oncol 2014; 16:771-778.
5. Granerod J, Ambrose HE, Davies NWS, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, et al.; UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10:835-844.
6. Mittal MK, Rabinstein AA, Hocker SE, Pittock SJ, Wijdicks EF, McKeon A. Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care 2016; 24:240-250.
7. Prüss H, Dalmau J, Harms L, Höltje M, Ahnert-Hilger G, Borowski K, Stoecker W, Wandinger KP. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010; 75: 1735-1739.
8. Vitaliani R, Mason W, Ances B, Zwerdling T, Jiang Z, Dalmau J. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005; 58:594-604.
9. Gable MS, Sheriff H, Dalmau J, Tilley DH, Glaser CA. The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012; 54:899-904.
10. Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC, Meyers E, Espinera A, Haas KF, Schmitt SE, et al.; Critical Care EEG Monitoring Research Consortium (CCEMRC). New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology 2015; 85:1604-1613.
11. Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10:63-74.
12. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12:157-165.
13. de Montmollin E, Demeret S, Brulé N, Conrad M, Dailler F, Lerolle N, Navellou J-C, Schwebel C, Alves M, Cour M, et al. French Intensive Care Society, International congress - Ré animation 2016. Ann Intensive Care 2016; 6:50.
14. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61:344-349.
15. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15: 391-404.
16. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7:1091-1098.
17. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-607.
18. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2:81-84.
19. Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, Stahl JP, Mailles A, Drebot M, Rupprecht CE, et al.; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 2013; 57: 1114-1128.
20. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, et al.; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17:3-23.
21. Titulaer MJ, McCracken L, Gabilondo I, Iizuka T, Kawachi I, Bataller L, Torrents A, Rosenfeld MR, Balice-Gordon R, Graus F, et al. Late-onset anti-NMDA receptor encephalitis. Neurology 2013; 81: 1058-1063.
22. Byrne S, Walsh C, Hacohen Y, Muscal E, Jankovic J, Stocco A, Dale RC, Vincent A, Lim M, King M. Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol Neuroinflamm 2015; 2:e130.
23. Tyler KL, Pape J, Goody RJ, Corkill M, Kleinschmidt-DeMasters BK. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology 2006; 66:361-365.
24. Young PJ, Baker S, Cavazzoni E, Erickson SJ, Krishnan A, Kruger PS, Rashid AH, Wibrow BA. A case series of critically ill patients with anti-N-methyl-D-aspartate receptor encephalitis. Crit Care Resusc 2013; 15:8-14.
25. Davies G, Irani SR, Coltart C, Ingle G, Amin Y, Taylor C, Radcliffe J, Hirsch NP, Howard RS, Vincent A, et al. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med 2010; 38:679-682.
26. Howard CM, Kass JS, Bandi VDP, Guntupalli KK. Challenges in providing critical care for patients with anti-N-methyl-D-aspartate receptor encephalitis. Chest 2014; 145:1143-1147.